 high doses of
pentoxifylline: Efﬁcacy in a randomized, placebo-controlled trial.
Wound Repair Regen 1999;7:208-13.
481. Dale JJ, Ruckley CV, Harper DR, Gibson B, Nelson EA, Prescott RJ.
Randomised, double blind placebo controlled trial of pentoxifylline in
the treatment of venous leg ulcers. BMJ 1999;319:875-8.
482. Mirshahi S, Soria J, Mirshahi M, et al. Expression of elastase and ﬁbrin
in venous leg ulcer biopsies: A pilot study of pentoxifylline versus
placebo. J Cardiovasc Pharmacol 1995;25(Suppl 2):S101-5.
483. Iglesias CP, Claxton K. Comprehensive decision-analytic model
and Bayesian value-of-information analysis: Pentoxifylline in the
treatment of chronic venous leg ulcers. Pharmacoeconomics 2006;24:
465-78.
484. Sullivan GW, Carper HT, Novick WJ Jr, Mandell GL. Inhibition of
the inﬂammatory action of interleukin-1 and tumor necrosis factor
(alpha) on neutrophil function by pentoxifylline. Infect Immun
1988;56:1722-9.
485. Heinen MM, Evers AW, Van Uden CJ, Van der Vleuten CJ, van de
Kerkhof PC, Van Achterberg T. Sedentary patients with venous or
mixed leg ulcers: Determinants of physical activity. J Adv Nurs
2007;60:50-7.
486. Heinen MM, van der Vleuten C, de Rooij MJ, Uden CJ, Evers AW, van
Achterberg T. Physical activity and adherence to compression therapy in
patients with venous leg ulcers. Arch Dermatol 2007;143:1283-8.
487. Roaldsen KS, Rollman O, Torebjork E, Olsson E